Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.

Literature DB >> 6237606

In vitro activities of teichomycin, fusidic acid, flucloxacillin, fosfomycin, and vancomycin against methicillin-resistant Staphylococcus aureus.

Abstract

Flucloxacillin, fosfomycin, fusidic acid, teichomycin, and vancomycin were tested against 50 clinical isolates of methicillin-resistant Staphylococcus aureus by a broth macrodilution technique. Teichomycin had a narrow range of activity, similar to that of vancomycin (0.5 to 2.0 micrograms/ml). Fusidic acid had the lowest range of inhibitory activity, with 50 and 90% MICs of 0.19 and 0.35 micrograms/ml, respectively. Flucloxacillin and fosfomycin showed less activity, with MICs up to 32 micrograms/ml.

Entities: Chemical Species

Mesh：

Substances：

Year: 1984 PMID： 6237606 PMCID： PMC284135 DOI： 10.1128/AAC.26.2.268

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

20 in total

1. Flucloxacillin in the treatment of infectious conditions in children.

Authors: J D Price; J W Harding
Journal: Curr Med Res Opin Date: 1975 Impact factor: 2.580

2. Methicillin-resistant staphylococci.

Authors: L P Garrod
Journal: Lancet Date: 1968-10-19 Impact factor: 79.321

3. Fucidin-resistant staphylococci in current hospital practice.

Authors: J R Pattison; P E Mansell
Journal: J Med Microbiol Date: 1973-05 Impact factor: 2.472

4. Bacteriological evaluation of fosfomycin in clinical studies.

Authors: A Rodríguez; A Gallego; T Olay; J M Mata
Journal: Chemotherapy Date: 1977 Impact factor: 2.544

5. Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties.

Authors: F Parenti; G Beretta; M Berti; V Arioli
Journal: J Antibiot (Tokyo) Date: 1978-04 Impact factor: 2.649

6. Flucloxacillin in bone.

Authors: P F Unsworth; F W Heatley; I Phillips
Journal: J Clin Pathol Date: 1978-08 Impact factor: 3.411

7. Activity of fosfomycin in the treatment of bacterial infections.

Authors: R Hutzler; V Fernandes; D Muñoz; A Rozentraub
Journal: Chemotherapy Date: 1977 Impact factor: 2.544

8. Interpretation of diffusion susceptibility data obtained with 10-mug fucidin (sodium fusidate) disks against clinical isolates of Staphylococcus aureus.

Authors: W H Traub; I Kleber
Journal: Chemotherapy Date: 1974 Impact factor: 2.544

9. The mechanism of action of fosfomycin (phosphonomycin).

Authors: F M Kahan; J S Kahan; P J Cassidy; H Kropp
Journal: Ann N Y Acad Sci Date: 1974-05-10 Impact factor: 5.691

10. Fosfomycin in chronic urinary infections.

Authors: A Allona; J A Díaz Cabrera; P Manchado
Journal: Chemotherapy Date: 1977 Impact factor: 2.544

15 in total

1. Intracellular bactericidal activity of fosfomycin against staphylococci: a comparison with other antibiotics.

Authors: M Trautmann; C Meincke; K Vogt; M Ruhnke; A M Lajous-Petter
Journal: Infection Date: 1992 Nov-Dec Impact factor: 3.553

2. Efficacy of pefloxacin-fosfomycin in experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.

Authors: C Thauvin; J F Lemeland; G Humbert; J P Fillastre
Journal: Antimicrob Agents Chemother Date: 1988-06 Impact factor: 5.191

3. Evaluation of teicoplanin and vancomycin disk susceptibility tests.

Authors: A L Barry; C Thornsberry; R N Jones
Journal: J Clin Microbiol Date: 1986-01 Impact factor: 5.948

4. In vitro and in vivo study of fosfomycin in methicillin-resistant Staphylococcus aureus septicaemia.

Authors: W Y Lau; C H Teoh-Chan; S T Fan; K F Lau
Journal: J Hyg (Lond) Date: 1986-06

5. Single- and combination-antibiotic therapy for experimental endocarditis caused by methicillin-resistant Staphylococcus aureus.

Authors: A Rodríguez; M V Vicente; T Olay
Journal: Antimicrob Agents Chemother Date: 1987-09 Impact factor: 5.191

6. Use of the Autobac system for detection of methicillin-resistant Staphylococcus aureus.

Authors: Y de Rautlin de la Roy; E Chevalier-Burbaud; S Pannetier; F Souchaud
Journal: J Clin Microbiol Date: 1985-09 Impact factor: 5.948

7. Activity of 18 antimicrobial agents against multi-resistant strains of Staphylococcus aureus isolated from intensive care patients.

Authors: D Duncker; U Ullmann
Journal: Infection Date: 1985 Sep-Oct Impact factor: 3.553